• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

WDI sees rebound in healthcare stocks

Article

For investors in healthcare stocks, 1995 was a much-needed shotin the arm that remedied a three-year period of falling shareprices. An annual survey by WDI Capital Markets of Hilton Head,SC, saw a strong surge in share prices among healthcare

For investors in healthcare stocks, 1995 was a much-needed shotin the arm that remedied a three-year period of falling shareprices. An annual survey by WDI Capital Markets of Hilton Head,SC, saw a strong surge in share prices among healthcare companieslast year. Vendors of cardiac instruments led the charge in stockvaluation growth, although manufacturers of medical imaging devicesturned in a strong performance as well.

For the year, overall healthcare industry share prices leaped40.1%, compared with a 4.7% decline in 1994. Share prices dropped9.4% in 1993 and 10.6% in 1992.

Among public imaging device companies, stock prices trackedby WDI climbed 75.8% in 1995, compared with a lackluster gainof 1.2% in 1994. ThermoTrex led the segment with share-price growthof 270%, while bone densitometry firm Hologic jumped 173%. Othervendors turning in strong performances for the year were bonedensitometry vendor Lunar, up 129%; image-guided catheter manufacturerEndosonics, up 122%; x-ray vendor Fischer Imaging, up 85%; andnuclear medicine firm ADAC Laboratories, up 55%.

Imaging services firms also enjoyed rising stock valuations,according to WDI's survey. Share prices in the segment rose anaverage of 52.2% for the year.

In other WDI news, the investment and advisory firm announcedthat former Fischer Imaging executive Robert Cascella has joinedthe company as president.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.